Multimodal treatment of neck lymphatic malformations in children

Cover Page

Cite item

Full Text

Abstract

Today, choosing the optimal management of patients with neck lymphatic malformations (NLM) remains a big challenge. In our study, we analyzed data of 115 patients with NLM who had received surgery and/or sclerotherapy at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia from May 2012 to December 2022 inclusive. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia. The median follow-up time from diagnosis verification was 21.4 months (Q1; Q3; 4.4; 58.3). Macrocystic lymphatic malformations were found to increase the probability of complete remission 7.4-fold (95% confidence interval (CI) 2.7–20.5; p < 0.001), while surgery performed either as single-modality therapy or in combination with other treatment increased it 6.3-fold (95% CI 2.3–16.9; p < 0.001). Disease stage ≥ III as classified by de Serres decreased the probability of complete remission fourfold (95% CI 1.5–10.9; p = 0.006), while CDS score ≤ 6 points – 3.2 fold (95% CI 1.3–8.4; p = 0.015). At the same time, disease stage ≥ III according to de Serres increased the risk of continued growth or a small (< 50%) reduction in NML volume 4.2-fold (95% CI 1.5–11.7; p = 0.007). Meanwhile, combined therapy and single-modality surgery increased the patients' survival time 7.4 fold (95% CI 2.0–27.8; p = 0.003) and 11.5 fold (95% CI 2.2–58.8; p = 0.004) respectively. Notably, only a relatively small number of minor (n = 22; 19.1%) and major (n = 9; 7.8%) postoperative complications were registered in our study. The results of our comprehensive analysis highlighted the importance of surgery as part of multimodal personalized treatment and laid the basis for a new algorithm for choosing the optimal management of patients with NLMs.

About the authors

G. A. Polev

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; Ilyinsky Hospital

Author for correspondence.
Email: dr.polev@gmail.com
ORCID iD: 0000-0002-7175-6417

Georgy A. Polev - Cand. Med. Sci., a senior researcher at the Department of Head and Neck Surgery and Reconstructive Plastic Surgery of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation, Director of Head and Neck Surgery Center at the Ilyinsky Hospital.

1 Samory Mashela St., 117997, Moscow

Russian Federation

N. S. Grachev

Ilyinsky Hospital

Email: nick-grachev@yandex.ru
ORCID iD: 0000-0002-4451-3233

Krasnogorsk

Russian Federation

R. S. Oganesyan

Ilyinsky Hospital

Email: raisaoganesyan@gmail.com
ORCID iD: 0000-0002-1698-2956

Krasnogorsk

Russian Federation

E. Yu. Yaremenko

Ilyinsky Hospital

Email: selvaggio@yandex.ru
ORCID iD: 0000-0003-1196-5070

Krasnogorsk

Russian Federation

References

  1. Chandra S.R., Nair A., Nair S. Terminology and Classifications of Vascular Lesions Based on Molecular Identification. Oral Maxillofac Surg Clin North Am 2024; 36 (1): 35-48. doi: 10.1016/j.coms.2023.09.010
  2. Kunimoto K., Yamamoto Y., Jinnin M. ISSVA Classification of Vascular Anomalies and Molecular Biology. Int J Mol Sci 2022; 23 (4). doi: 10.3390/ijms23042358
  3. Abramov A.A., Avanesov V.M., Adamyan A.A., Andreeva Yu.Yu., Anurova O.A., Arutyunyan L.S., et al. Head and neck tumors: treatment and rehabilitation technologies: tissue reconstruction. М.; 2016. (In Russ.)].
  4. Acevedo J.L., Shah R.K., Brietzke S.E. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Neck Surg 2008; 138 (4): 418–24. doi: 10.1016/j.otohns.2007.11.018
  5. Harsha W.J., Perkins J.A., Lewis C.W., Manning S.C. Pediatric admissions and procedures for lymphatic malformations in the United States: 1997 and 2000. Lymphat Res Biol 2005; 3 (2): 58–65. doi: 10.1089/lrb.2005.3.58
  6. Ryu J.Y., Chang Y.J., Lee J.S., Choi K. Y., Yang J.D., Lee S.-J., et al. A nationwide cohort study on incidence and mortality associated with extracranial vascular malformations. Sci Rep 2023; 13 (1): 13950. doi: 10.1038/s41598-023-41278-z
  7. Andrews L., Shope C., Lee L.W., Hochman M. Vascular Anomalies: Nomenclature and Diagnosis. Dermatol Clin 2022; 40 (4): 339–43. doi: 10.1016/j.det.2022.06.007
  8. Murayev A.A., Guseynov N.A., Tsay P.A., Kibardin I.A., Burenchev D.V., Ivanov S.S., et al. Artificial neural networks in diagnostic imaging, dentistry and maxillofacial surgery (literature review). Clinical dentistry 2020; 3 (95): 72–80. (In Russ.)
  9. Ricci K.W., Iacobas I. How we approach the diagnosis and management of complex lymphatic anomalies. Pediatr Blood Cancer 2022; 69 Suppl 3: e28985. doi: 10.1002/pbc.28985
  10. Sagoyan G.B., Kachanov D.Yu., Grachev N.S., Mitrofanova A.M., Moiseenko R.A., Vorozhtcov I.N., et al. Congenital immature teratoma of head and neck: case report. Pediatric Hematology/Oncology and Immunopathology 2017; 16 (3): 73–80. (In Russ.) doi: 10.24287/1726-1708-2017-16-3-73-80
  11. Shamshirsaz A.A., Stewart K.A., Erfani H., Nassr A.A., Sundgren N.C., Mehollin-Ray A.R., et al. Cervical lymphatic malformations: Prenatal characteristics and ex utero intrapartum treatment. Prenat Diagn 2019; 39 (4): 287–92. doi: 10.1002/pd.5428
  12. Richardson C.M., Perkins J.N., Zenner K., Bull C., Lutsky E., Jensen D.M., et al. Primary targeted medical therapy for management of bilateral head and neck lymphatic malformations in infants. Int J Pediatr Otorhinolaryngol 2023; 164: 111371. doi: 10.1016/j.ijporl.2022.111371
  13. Bouwman F.C.M., Verhoeven B.H., Klein W.M., Schultze Kool L.J., de Blaauw I. Congenital Vascular Malformations in Children: From Historical Perspective to a Multidisciplinary Approach in the Modern Era-A Comprehensive Review. Children (Basel) 2024; 11 (5): 567. doi: 10.3390/children11050567
  14. Huerta C.T., Beres A.L., Englum B.R., Gonzalez K., Levene T., Wakeman D., et al. Management and Outcomes of Pediatric Lymphatic Malformations: A Systematic Review From the APSA Outcomes and Evidence-Based Practice Committee. J Pediatr Surg 2024; 59 (10): 161589. doi: 10.1016/j.jpedsurg.2024.05.019
  15. Embrechts J.L.A., Hiddinga S., Bot J.C., Hendrickx J.-J., van Eekelen R., Ket J. C.F., et al. Surgery versus sclerotherapy versus combined therapy in head and neck lymphatic malformations in the pediatric population: systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2024; 281 (9): 4529–39. doi: 10.1007/s00405-024-08661-6
  16. De Maria L., De Sanctis P., Balakrishnan K., Tollefson M., Brinjikji W. Sclerotherapy for lymphatic malformations of head and neck: Systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 2020; 8 (1): 154–64. doi: 10.1016/j.jvsv.2019.09.007
  17. Kalwani N.M., Rockson S.G. Management of lymphatic vascular malformations: A systematic review of the literature. J Vasc Surgery Venous Lymphat Disord 2021; 9 (4): 1077–82. doi: 10.1016/j.jvsv.2021.01.013
  18. Wiegand S., Dietz A., Wichmann G. Efficacy of sirolimus in children with lymphatic malformations of the head and neck. Eur Arch Otorhinolaryngol 2022; 279 (8): 3801–10. doi: 10.1007/s00405-022-07378-8
  19. Saibene A.M., Rosso C., Felisati G., Pignataro L., Schindler A., Ghilardi G., et al. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review. Eur Arch Otorhinolaryngol 2023; 280 (8): 3529–40. doi: 10.1007/s00405-023-07991-1
  20. Kamhieh Y., Mitra R., Burnett T., Jones H., Roblin G., Hall A. Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta-Analysis. Laryngoscope 2024; 134 (5): 2038–47. doi: 10.1002/lary.31091
  21. Bonilla-Velez J., Whitlock K.B., Ganti S., Theeuwen H.A., Manning S.C., Bly R.A., et al. Active Observation as an Alternative to Invasive Treatments for Pediatric Head and Neck Lymphatic Malformations. Laryngoscope 2021; 131 (6): 1392–7. doi: 10.1002/lary.29180
  22. Colletti G., Chiarini L. Lymphatic malformations do not regress spontaneously. J Pediatr Surg 2022; 57 (8): 1711. doi: 10.1016/j.jpedsurg.2022.02.014
  23. Thorburn C., Price D. Expectant management of pediatric lymphatic malformations: A 30-year chart review. J Pediatr Surg 2022; 57 (5): 883–7. doi: 10.1016/j.jpedsurg.2021.12.053
  24. Smith R.J.H. Lymphatic malformations. Lymphat Res Biol 2004; 2 (1): 25–31. doi: 10.1089/1539685041690436
  25. Rumyantsev A.G., Varfolomeeva S.R., Karachunskiy A.I., Grachev N.S., Novichkova G.A. The principles and tools of evi-dence-based medicine in pediatric hematology/oncology. Doctor. Ru 2015; 10 (111): 6–13. (In Russ.).
  26. de Serres L.M., Sie K.C., Richardson M.A. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg 1995; 121 (5): 577–82. doi: 10.1001/archotol.1995.01890050065012
  27. Polev G.A., Grachev N.S., Oganesyan R.S., Yaremenko E.Yu. Risk factors for functional state deterioration in patients with lymphatic malformation occuring in the neck region. Medical Council 2024; (11): 202–9. (In Russ.). 9. doi: 10.21518/ms2024-247
  28. Wittekindt C., Michel O., Streppel M., Roth B., Quante G., Beutner D., Guntinas-Lichius O. Lymphatic malformations of the head and neck: introduction of a disease score for children, Cologne Disease Score (CDS). Int J Pediatr Otorhinolaryngol 2006; 70 (7): 1205–12. doi: 10.1016/j.ijporl.2005.12.013
  29. Li J., Zhong W., Geng X., Liu X., Zhang X., Wang Y., Li H. Ultrasonographic diagnosis, classification, and treatment of cervical lymphatic malformation in paediatric patients: a retrospective study. BMC Pediatr 2020; 20 (1): 441. doi: 10.1186/s12887-020-02337-w
  30. Sun J., Wang C., Li J., Song D., Guo L. The efficacy of bleomycin sclerotherapy in the treatment of lymphatic malformations: a review and meta-analysis. Braz J Otorhinolaryngol 2023; 89 (4): 101285. doi: 10.1016/j.bjorl.2023.101285
  31. Wang Y., Tang W., Li X. Safety and efficacy of surgery combined with bleomycin irrigation for complex cervical-facial lymphatic malformations of children. Int J Pediatr Otorhinolaryngol 2020; 128: 109724. doi: 10.1016/j.ijporl.2019.109724
  32. Cahill A.M., Nijs E., Ballah D., Thompson L., Rintoul N., Hedrick H., et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg 2011; 46 (11): 2083–95. doi: 10.1016/j.jpedsurg.2011.07.004
  33. Greinwald J.J., Cohen A.P., Hemanackah S., Azizkhan R.G. Massive lymphatic malformations of the head, neck, and chest. J Otolaryngol Head Neck Surg 2008; 37 (2): 169–73.
  34. Bonilla-Velez J., Moore B.P., Cleves M.A., Buckmiller L., Richter G.T. Surgical resection of macrocystic lymphatic malformations of the head and neck: Short and long-term outcomes. Int J Pediatr Otorhinolaryngol 2020; 134: 110013. doi: 10.1016/j.ijporl.2020.110013
  35. Zhou Q., Zheng J.W., Mai H.M., Luo Q.F., Fan X.D., Su L.X., et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 2011; 47 (12): 1105–9. doi: 10.1016/j.oraloncology.2011.08.001

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Polev G.A., Grachev N.S., Oganesyan R.S., Yaremenko E.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.